Veracyte Inc (VCYT) support and resistance · P/E 47, rev $289.4M
Veracyte Inc (VCYT) is a diagnostics & research company listed on NASDAQ.
This page maps Veracyte Inc (VCYT) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported VCYT revenue for 2026-06-30 was $289.4M. Net income was $54.2M. VCYT currently screens at market cap $4.09B and trailing P/E 47.5.
VCYT currently screens at market cap $4.09B and trailing P/E 47.5. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new VCYT 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the VCYT quote page for the session range and the stock page for the full model.
Not investment advice.